|
ISY1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.514100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.174800E-01 |
| Normal-vs-Stage2 |
3.056300E-03 |
| Normal-vs-Stage3 |
1.382460E-03 |
| Normal-vs-Stage4 |
9.500300E-02 |
| Stage1-vs-Stage2 |
4.223700E-03 |
| Stage1-vs-Stage3 |
1.500110E-03 |
| Stage1-vs-Stage4 |
2.134200E-01 |
| Stage2-vs-Stage3 |
6.017800E-01 |
| Stage2-vs-Stage4 |
1.388840E-01 |
| Stage3-vs-Stage4 |
1.851800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.155710E-02 |
| Normal-vs-AfricanAmerican |
9.584800E-01 |
| Normal-vs-Asian |
9.531600E-01 |
| Caucasian-vs-AfricanAmerican |
6.043700E-02 |
| Caucasian-vs-Asian |
4.719200E-01 |
| AfricanAmerican-vs-Asian |
9.798400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.975100E-03 |
| Normal-vs-Female |
5.136200E-01 |
| Male-vs-Female |
7.416900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.969000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.355200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.817580E-02 |
| Normal-vs-Age(81-100Yrs) |
1.99337999999827E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.140000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.904420E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.363700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.077800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.589600E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.879900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.621620E-03 |
| Normal-vs-Grade 2 |
3.421200E-01 |
| Normal-vs-Grade 3 |
2.159400E-03 |
| Normal-vs-Grade 4 |
3.095600E-02 |
| Grade 1-vs-Grade 2 |
6.636900E-04 |
| Grade 1-vs-Grade 3 |
3.16000000000205E-06 |
| Grade 1-vs-Grade 4 |
3.648700E-04 |
| Grade 2-vs-Grade 3 |
4.484100E-03 |
| Grade 2-vs-Grade 4 |
9.806100E-02 |
| Grade 3-vs-Grade 4 |
7.514400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.205400E-01 |
| Normal-vs-ccB subtype |
3.566300E-04 |
| ccA subtype-vs-ccB subtype |
2.397800E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.657800E-02 |
| Normal-vs-N1 |
3.504400E-01 |
| N0-vs-N1 |
8.370800E-01 |
|
|
